Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism SLC39A7 inhibitors(solute carrier family 39 member 7 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H28FN5OS |
InChIKeyFZOFDZMKSAUTHT-NRFANRHFSA-N |
CAS Registry2349367-89-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Preclinical | CH | 14 Jan 2019 |